Cervical Cancer | COVID Vaccine | RAS and p53, Cancer Information Highlights, 04/14/2021

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
New from NCI
Making Cervical Cancer a Thing of the Past
NCA50 Nothing Will Stop Us   Learn how Drs. Doug Lowy and John Schiller developed the human papillomavirus (HPV) vaccine, which can prevent 90% of HPV-related cancers, including cervical cancer. Also, read the story of Dr. Vikrant Sahasrabuddhe who wants to increase cervical cancer screening rates by proving that self-sampling for HPV is as good as screening done in a clinical setting.
Coronavirus Vaccines and People with Cancer
SET THIS ALT TEXT   People with cancer and their caregivers still have questions about COVID-19 vaccines. This story from February 10, 2021, has been updated to answer common questions NCI's Cancer Information Service gets about COVID-19 vaccines and people with cancer.
Researchers Create Modified Antibodies to Target RAS and p53 in Cancer
antibodies (that look like ribbons) act like a bridge, grabbing onto immune cells with one end and cancer cells with the other.   Researchers have come up with a clever way to target RAS and p53, two of the most common proteins linked to cancer. In a series of studies, the scientists designed antibodies that shrank tumors in mice with these mutant proteins.
Immunotherapy Drug Improves Survival in Children with Relapsed Leukemia

The immunotherapy drug blinatumomab (Blincyto) works better than chemotherapy in treating B-cell acute lymphoblastic leukemia that has relapsed in children and young adults.
Whole-Genome Sequencing Could Help Guide AML Treatment

For people with acute myeloid leukemia (AML) and related cancers, a new study shows whole-genome sequencing could replace a series of tests usually used to help guide decisions about treatment.

PDQ Updates
Cancer Prevention Overview

We’ve revised this summary with updated information about the role of aspirin use and how it is not shown to prevent most cancers.
Cigarette Smoking: Health Risks and How to Quit

We’ve added information about the rate of cigarette smoking among high school students dropping from 20% to 30% during the early 1990s to 6% by 2019.
FDA Approvals
Tivozanib Hydrochloride

We’ve added a new drug summary for tivozanib hydrochloride (Fotivda), which the Food and Drug Administration recently approved to treat advanced kidney cancer that has been treated with two or more types of systemic therapy and has come back or did not respond to treatment.
Also of Interest
Coronavirus: What People with Cancer Should Know

Some cancer treatments may increase your risk of severe illness from COVID-19. On this page, updated March 31, learn how people with cancer can protect themselves and what they should do if they have symptoms of an infection.
Contact Us for Help

Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.